Research and Development

Showing 15 posts of 9607 posts found.

dna-1903319_960_720

Small number of mutations driving most cancers

October 20, 2017 Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …
celgene_building

Celgene drops $710m drug, shares nosedive 7%

October 20, 2017 Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …
portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
lilly_entrance_web

Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership

October 19, 2017 Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …
shutterstock_212432119

First-ever study in the personalised treatment of rare cancers brings promising results

October 18, 2017 Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer

The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …
mit-ai-cancer-detection-01_0

Breakthrough AI able to identify 97% of breast cancer risk

October 18, 2017 Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …

Novartis sheds generics plant and 450 jobs amid pricing pressure

October 18, 2017 Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …
nhs_trees

New studies point to cracks forming in NHS services

October 18, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …

J&J’s third quarter: The good and the bad

October 18, 2017 Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …

Allergan’s patent shield – The (Native) American dream?

October 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

  In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …
shutterstock_159488225

AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours

October 17, 2017 Manufacturing and Production, Research and Development AstraZeneca, Cancer, Chi-Med, lung cancer, pharma, savolitinib

AstraZeneca and its partner Hutchison China MedTech, also known as Chi-Med, have announced positive data for savolitinib in combination with …
peanuts

Peanut allergies? There’s a clinical trial looking to fix that

October 17, 2017 Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical

Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …
shutterstock_79370437

Asking the right questions: Measuring the impact of pharmacovigilance

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …
veeva

Simplify your regulatory processes

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …
prevail_-_ebola_vaccination

Trials reveal two strong vaccine candidates for Ebola

October 16, 2017 Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical

Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
The Gateway to Local Adoption Series

Latest content